SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-024926
Filing Date
2024-10-09
Accepted
2024-10-09 16:09:11
Documents
2
Period of Report
2024-10-07

Document Format Files

Seq Description Document Type Size
1 form3-10092024_081007.html 3  
1 form3-10092024_081007.xml 3 1682
2 ex24-10092024_081009.htm EX-24 4484
  Complete submission text file 0001415889-24-024926.txt   7698
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Business Address
Sauvage Philippe (Reporting) CIK: 0002039891 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39351 | Film No.: 241362871